Rapid detection of pyrazinamide resistant Mycobacterium tuberculosis by high resolution melting curve analysis

Journal of the Medical Association of Thailand

Volumn 96, Issue 9, 2013, Pages 1218-1223

  Watcharasamphankul, Worawan ^a   Houpt, Eric R ^b   Foongladda, Suporn ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Drug resistant; High resolution melting curve analysis; Mycobacterium; PncA gene; Pyrazinamide

Indexed keywords

PYRAZINAMIDE;

ARTICLE; BACTERIUM DETECTION; CONTROLLED STUDY; DNA EXTRACTION; DNA SEQUENCE; DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; HIGH RESOLUTION MELTING ANALYSIS; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION;

ANTITUBERCULAR AGENTS; DNA PRIMERS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID DENATURATION; POLYMERASE CHAIN REACTION; PYRAZINAMIDE; TRANSITION TEMPERATURE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84884158527     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Zhang Y, Mitchison D. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 2003; 7: 6-21.
2. Hannan MM, Desmond EP, Morlock GP, Mazurek GH, Crawford JT. Pyrazinamide-monoresistant Mycobacterium tuberculosis in the United States. J Clin Microbiol 2001; 39: 647-650.
3. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, et al. Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2011; 55: 2032-2041.
4. Scorpio A, Lindholm-Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, et al. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997; 41: 540-543.
5. Cheng SJ, Thibert L, Sanchez T, Heifets L, Zhang Y. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada. Antimicrob Agents Chemother 2000; 44: 528-532.
6. Davies AP, Billington OJ, McHugh TD, Mitchison D., Gillespie SH. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J Clin Microbiol 2000; 38: 3686-3688.
7. Cole ST. Microbiology. Pyrazinamide-old TB drug finds new target. Science 2011; 333: 1583-1584.
8. Mohamed AM, Bastola DR, Morlock GP, Cooksey RC, Hinrichs SH. Temperature-mediated heteroduplex analysis for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high-performance liquid chromatography. J Clin Microbiol 2004; 42: 1016-1023.
9. Felmlee TA, Liu Q, Whelen AC, Williams D, Sommer SS, Persing DH. Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting. J Clin Microbiol 1995; 33: 1617-1623.
10. Fan XY, Hu ZY, Xu FH, Yan ZQ, Guo SQ, Li ZM. Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in shanghai by using the amplification refractory mutation system. J Clin Microbiol 2003; 41: 993-997.
11. Thomas GA, Williams DL, Soper SA. Capillary electrophoresis-based heteroduplex analysis with a universal heteroduplex generator for detection of point mutations associated with rifampin resistance in tuberculosis. Clin Chem 2001; 47: 1195-1203.
12. Hirano K, Takahashi M, Kazumi Y, Fukasawa Y, Abe C. Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tuber Lung Dis 1997; 78: 117-122.
13. Louw GE, Warren RM, Donald PR, Murray MB, Bosman M, Van Helden PD, et al. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int J Tuberc Lung Dis 2006; 10: 802-807.
14. Lee KW, Lee JM, Jung KS. Characterization of pncA mutations of pyrazinamide-resistant Mycobacterium tuberculosis in Korea. J Korean Med Sci 2001; 16: 537-543.
15. Lemaitre N, Sougakoff W, Truffot-Pernot C, Jarlier V. Characterization of new mutations in pyrazinamide-resistant strains of Mycobacterium tuberculosis and identification of conserved regions important for the catalytic activity of the pyrazinamidase PncA. Antimicrob Agents Chemother 1999; 43: 1761-1763.